Academic Journal
POSTER: MDS-604 Improvement of Patient-Reported Fatigue in IMerge Phase 3 Trial of Imetelstat vs Placebo in Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory/Ineligible for Erythropoiesis-Stimulating Agents
| العنوان: | POSTER: MDS-604 Improvement of Patient-Reported Fatigue in IMerge Phase 3 Trial of Imetelstat vs Placebo in Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory/Ineligible for Erythropoiesis-Stimulating Agents |
|---|---|
| المؤلفون: | Sekeres, Mikkael, Santini, Valeria, Díez-Campelo, Maria, Komrokji, Rami, Fenaux, Pierre, Savona, Michael, Madanat, Yazan, Valcárcel-Ferreiras, David, Illmer, Thomas, Jonášová, Anna, Bělohlávková, Petra, Regnault, Antoine, Creel, Kristin, Sengupta, Nishan, Sherman, Laurie, Berry, Tymara, Dougherty, Souria, Shah, Sheetal, Xia, Qi, Sun, Libo, Wan, Ying, Huang, Fei, Ikin, Annat, Navada, Shymala, Feller, Faye, Zeidan, Amer, Platzbecker, Uwe |
| المصدر: | Clinical Lymphoma Myeloma and Leukemia ; volume 23, page S186 ; ISSN 2152-2650 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s2152-2650(23)00612-2 |
| الاتاحة: | http://dx.doi.org/10.1016/s2152-2650(23)00612-2 https://api.elsevier.com/content/article/PII:S2152265023006122?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S2152265023006122?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
| رقم الانضمام: | edsbas.590A13B7 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s2152-2650(23)00612-2 |
|---|